On April 2, CMS published their final rule for contract year 2019 that revises regulations related to Medicare Advantage (MA) and the Prescription Drug Benefit Program (Part D). The primary focus of this rule is to implement provisions from the Comprehensive Addiction and Recovery Act (CARA) to help fight the opioid epidemic, implement provisions from the 21st Century Cures Act and […]
We all know healthcare is changing, and the driver for much of this change is the government. MACRA (Medicare Access and CHIP Reauthorization Act of 2015), the latest sweeping healthcare reform law from Congress, is being massaged by CMS, and while most believe it is the physician at the tip of the MACRA spear, it […]
Read our latest specialty pharmacy insight report here.